Akt1 in osteoblasts and osteoclasts controls bone remodeling

Area of Science:

• Bone biology and cellular signaling pathways.
• Molecular mechanisms of osteoblast and osteoclast regulation.
• Signaling pathways in bone metabolism.

Background:

• Bone mass and turnover depend on balanced osteoblast and osteoclast activity.
• Phosphoinositide-dependent serine-threonine protein kinase Akt (Akt) is vital for bone anabolic factor signaling.
• Akt1 is a key Akt isoform in bone cells.

Purpose of the Study:

• To investigate the role of Akt1 in maintaining bone mass and turnover.
• To elucidate the molecular mechanisms underlying Akt1's function in osteoblasts and osteoclasts.
• To identify potential therapeutic targets for bone disorders.

Main Methods:

• Disruption of Akt1 in mice to study bone phenotypes.
• Ex vivo cell culture analyses of osteoblasts and osteoclasts.
• Investigation of the Akt1/forkhead box class O (FoxO) 3a/Bim signaling axis.
• Analysis of receptor activator of nuclear factor-kappaB ligand (RANKL) expression.

Main Results:

• Akt1 disruption in mice resulted in low-turnover osteopenia due to osteoblast and osteoclast dysfunction.
• Osteoblast dysfunction involved increased apoptosis and decreased runt-related transcription factor 2 (Runx2) activity.
• A novel Akt1/FoxO3a/Bim pathway regulating osteoblast apoptosis was identified.
• Osteoclast dysfunction included impaired differentiation/survival and reduced RANKL expression by osteoblasts.

Conclusions:

• Akt1 is essential for osteoblast and osteoclast differentiation and survival, thereby maintaining bone mass.
• The Akt1/FoxO3a/Bim axis is a novel regulator of osteoblast apoptosis.
• Understanding this molecular network provides a basis for developing therapeutic strategies for bone diseases.